Pharmacodynamics, pharmacokinetics and safety of GSK2190915, a novel oral anti-inflammatory 5-lipoxygenase-activating protein inhibitorBritish Journal of Clinical Pharmacology
Volume 75, Issue 3, March 2013, Pages: 779–790, Gretchen Bain, Christopher D. King, Kevin Schaab, Melissa Rewolinski, Virginia Norris, Claire Ambery, Jane Bentley, Masanori Yamada, Angelina M. Santini, Jeroen van de Wetering de Rooij, Nicholas Stock, Jasmine Zunic, John H. Hutchinson and Jilly F. Evans
Article first published online : 5 FEB 2013, DOI: 10.1111/j.1365-2125.2012.04386.x